MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment
Hand-out
Press Releases
MimiVax, Inc.  
January 10, 2025

MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment

SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facilityUI Pharmaceuticals is looking forward to supporting the need for larger clinical and commercial lotsMimiVax is utilizing

logo salamanca press

Salamanca Press

Local & Social